Epidermodysplasia verruciformis: association with isolated IgM deficiency and response to treatment with acitretin.
We describe a 25-year-old woman, who had extensive, large viral warts consistent with epidermodysplasia verruciformis (EV) since she was 6-year-old. Laboratory studies revealed an isolated IgM-deficiency, but the patient demonstrated no other abnormalities. She was treated with oral acitretin (0.5-1 mg/kg/day) for six months and her skin lesions improved slightly. However, after discontinuing the treatment, the lesions came back but she declined further treatment.
Iraji
F
F
Department of Dermatology, St. Zahra University Hospital, Isfahan, Iran.
Faghihi
G
G
D017255:Acitretin / Q000627:therapeutic use; D000328:Adult; D004819:Epidermodysplasia Verruciformis / Q000188:drug therapy / Q000276:immunology*; D005260:Female; D006801:Humans; D007075:Immunoglobulin M / Q000172:deficiency*; D007641:Keratolytic Agents / Q000627:therapeutic use
D007075:Immunoglobulin M; D007641:Keratolytic Agents; D017255:Acitretin